Radiotheranostics - a Primer for Medical Physicists II : Radiochemistry, Radiobiology, Dosimetry, Safety, Economics, and AI (Series in Medical Physics and Biomedical Engineering)

個数:
  • ポイントキャンペーン

Radiotheranostics - a Primer for Medical Physicists II : Radiochemistry, Radiobiology, Dosimetry, Safety, Economics, and AI (Series in Medical Physics and Biomedical Engineering)

  • ウェブストア価格 ¥55,264(本体¥50,240)
  • CRC Press(2025/11発売)
  • 外貨定価 US$ 250.00
  • 【ウェブストア限定】洋書・洋古書ポイント5倍対象商品(~2/28)
  • ポイント 2,510pt
  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 256 p.
  • 言語 ENG
  • 商品コード 9781032659701
  • DDC分類 616.9440642

Full Description

Radiotheranostics - A Primer for Medical Physicists II: Radiochemistry, Radiobiology, Dosimetry, Safety, Economics, and AI expands upon the radiotheranostic topics in cancer care covered in Volume I, which includes cancer biology, clinical applications, radionuclide production, source calibration, imaging instrumentation, and staff education, training, and competencies. Building on these foundational elements, Volume II offers an in-depth coverage of radiopharmaceutical preparation and radiolabeling strategies. It presents new insights into radiation biology, including studies on human and animal radiation embryology. The dosimetry section addresses alpha-, beta-, and Auger-emitting radionuclides and explores the therapeutic potential of positrons. It emphasizes biokinetic modeling, standardized and image-based dosimetry procedures, and the quantification of uncertainties in dose calculations. Essential safety topics are also thoroughly examined, including radiation shielding, facility design, the management of deceased radiotheranostic patients, and current regulatory requirements. The volume concludes with forward-looking chapters on the economics of theranostics and the transformative role of artificial intelligence in enhancing precision medicine.

The chapters are designed to equip medical physicists with the tools necessary to accurately estimate and document individual patient dosimetry and demonstrate the clinical value of dose calculations in improving cancer outcomes and survival rates.

The book is intended for academic and practicing clinical medical and health physicists with a basic knowledge of nuclear medicine. Although not structured as a textbook, medical physicists in nuclear medicine physics training will also find the book helpful.

Key Features:

Covers everything medical and health physicists need to know in one book
The text is rigorous yet easily understandable to physics majors
References are extensive so that readers can delve deeper into the subject

Contents

List of Common Acronyms

Part 1 - Introduction

Chapter 1. Radiotheranostics: Challenges Today

Part 2 - Radiochemistry and Radiobiology

Chapter 2. Radiopharmaceutical Preparations and Radiolabeling Strategies

Chapter 3. New Insights Into the Radiation Biology of Radiotheranostics

Chapter 4. Radiation Embryology: Human and Animal Studies

Part 3 - Particle Dosimetry

Chapter 5. Alpha- and Beta-particle Therapy and Dosimetry

Chapter 6. Auger Emitters

Chapter 7. Positrons: Their Potential Role in Radionuclide Therapy

Part 4 - Dosimetry Formalisms

Chapter 8. Biokinetic Modelling For Radionuclide Dosimetry

Chapter 9. Standardized Tumor and Organ Dosimetry

Chapter 10. Image-based Dosimetry Procedures

Chapter 11. Combining External Beam Radiotherapy and Radionuclide Therapy

Chapter 12. Uncertainties in Dose Calculations

Part 5 - Safety

Chapter 13. Design, Shielding, and Operational Radiation Safety Aspects of the Radiotheranostic Facility

Chapter 14. Management of Deceased Patients Under Treatment (Radioactive Cadavers)

Chapter 15. Radiopharmaceutical Regulatory Requirements

Part 6 - Future Directions and Opportunities

Chapter 16. The Economics of Theranostics

Chapter 17. Artificial intelligence in Radiotheranostics

最近チェックした商品